Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 17067414

Multilevel component analysis.

Marieke E Timmerman
View original source ↗Export metadata ↓

Abstract

A general framework for the exploratory component analysis of multilevel data (MLCA) is proposed. In this framework, a separate component model is specified for each group of objects at a certain level. The similarities between the groups of objects at a given level can be expressed by imposing constraints on component models of the groups using the approach adopted in simultaneous component analysis. The constraints used are based on the loading matrices and on the covariances of the component scores of each group. MLCA is related to three-way component analysis and to currently available multilevel structural equation models. It is shown that the latter are less flexible than MLCA. The use of MLCA is illustrated by means of an empirical example.

Explore related subjects

ComorbidityData CollectionData Interpretation, StatisticalHumansIndividualityLinear ModelsMathematical ComputingMood DisordersParkinson DiseasePersonality InventoryPrincipal Component AnalysisPsychometricsSurveys and QuestionnairesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Marieke E Timmerman. 2006. Multilevel component analysis.. https://doi.org/10.1348/000711005x67599

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Assessing the comorbidity between asthma and depression through polygenic risk scoring and time-to-event models.

BACKGROUND: Patients with asthma have an increased risk of developing depression, affecting their quality of life. To date, the processes contributing to this comorbidity remain unclear. METHODS: We integrated two large genome-wide association studies (88,486 patients with asthma and 447,859 controls; 412,024 patients with depression and 1,587,577 controls) with cross-sectional and longitudinal information available from the All of Us Research Program (N = 87,167) through polygenic risk scoring (PRS), Cox proportional-hazards models, one-sample Mendelian randomization (MR), and gene-set and drug-repurposing analyses. RESULTS: We observed that depression PRS was associated with increased asthma risk (hazard ratio, HR = 1.13, 95% CI = 1.09-1.17), also when accounting for comorbidity status (HR = 1.08, 95% CI = 1.04-1.12). Conversely, the effect of asthma PRS was null after accounting for comorbidity status. One-sample MR analysis showed an effect of depression genetic liability on asthma, ranging from beta = 0.36 ± 0.03 when considering a linear relationship to beta = 3.21 ± 0.31 when considering possible nonlinear relationships. Conversely, the effect of asthma genetic risk on depression was null after accounting for potential confounders. The gene-set analyses showed that asthma and depression polygenic risks share biological processes, molecular functions, and cellular components related to the immune system and the lung-brain axis. CONCLUSIONS: Genetic predisposition contributes to asthma-depression comorbidity through direct effects and shared pathogenic processes. These findings highlight the potential to develop targeted interventions to prevent and treat the co-occurrence of respiratory and neuropsychiatric disorders.

Comorbidity↗